The case for & against
Bull & Bear analysis
Unilever PLC (NYSE: UL) is a leading global consumer goods company known for its vast range of products spanning categories such as Beauty & Wellbeing, Personal Care, Home Care, and Foods. The company’s strategic focus on profitable growth and innovation has increasingly targeted premium segments, which positions it well in the evolving consumer market landscape. Given its significant portfolio of established brands and progressive approach to sustainability and efficiency, Unilever is entrenched in the broader theme of consumer goods adapting to new market dynamics, particularly in emerging markets.
Bull says
- ↑Underlying sales grew 4.2% in Q4; volume up 2.1%.
- ↑Operating margin expanded 60 bp to 20% in 2026.
- ↑Free cash flow of €5.9 bn at 100% conversion.
- ↑Attractive 1.25% dividend yield; management reinvests dividends.
- ↑Strong profitability, low leverage, and stable volatility profile.
- ↑Emerging markets (59% of sales) and premium brands drive growth.
Bear says
- ↓Management guides underlying sales growth at low end of 4–6%.
- ↓Negative earnings revisions and uncertain volumes may weigh on EPS.
- ↓Commodity cost inflation squeezes Home Care and Personal Care margins.
- ↓Weak growth momentum suggests tougher expansion ahead.
- ↓Elevated short interest reflects investor skepticism on near-term outlook.
- ↓Macroeconomic volatility and compliance costs could further pressure profits.
Investment themes with UL
Stable developed market with finance and pharmaceuticals
Earnings Call · Q4 2025 · Mgmt. Guidance
Transcript signals
Bull points
- For the full year, underlying sales growth was 3.5%, with volumes at 1.5% and price at 2%. Looking beyond the single year, performance over a 2-year period highlights the underlying momentum of the business, particularly in Beauty & Wellbeing, Home Care and Personal Care, we delivered compounded annual volume growth of 3.6%, 3.1% and 2.1%, respectively.
- Our 30 Power Brands, which represent more than 78% of the group turnover, continue to grow ahead of the average, delivering 4.3% underlying sales growth for the full year with volumes up 2.2%, in line with our medium-term growth algorithm.
- Beauty & Wellbeing delivered balanced growth across the year with underlying sales growth of 4.3%, evenly split between volume of 2.2% and price at 2.1%. Dove, Vaseline and our premium brands continued to outperform, delivering double-digit growth, reflecting the strength of our innovation and focused execution.
Bear points
- In Latin America, underlying sales grew 0.5% for the year, reflecting a broad-based market slowdown amid ongoing macro and political uncertainty.
- we expect conditions to remain challenging, with soft markets in many parts of the world.
- Our share buyback programs contributed 1.5% to underlying EPS. These positives were mainly offset by currency, which had a negative impact of 8.8% on the underlying earnings per share.